ICU Medical, Inc.
Financials
Valuation Metrics
ICU Medical, Inc.'s Market Cap is $4.32B. At end of 2025 it was $3.52B. Ranked #1507 of 3,112 in US market (top 48%), #522 of 1,445 on NASDAQ (top 36%), #88 of 206 in Health Care Equipment & Services (top 43%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $4.32B | US#1,507/3,112 Sec#88/206 |
| Revenue | $2.16B | US#1,434/3,112 Sec#90/206 |
| Net Income | $46M | US#1,883/3,112 Sec#89/206 |
| Total Assets | $4.01B | US#1,593/3,112 Sec#74/206 |
| Net Assets | $2.11B | US#1,210/3,112 Sec#61/206 |
| Employees | 13,000 | US#512/3,112 Sec#49/206 |
| Value | ||
| P/E | 93.31x | US#2,041/3,112 Sec#105/206 |
| P/B | 2.05x | US#1,217/3,112 Sec#69/206 |
| P/S | 2.00x | US#1,267/3,112 Sec#92/206 |
| EV/EBITDA | 20.47x | US#1,879/3,112 Sec#84/206 |
| FCF Yield | 1.86% | US#1,986/3,112 Sec#127/206 |
| Profitability | ||
| ROE | 2.19% | US#2,040/3,112 Sec#103/206 |
| ROA | 1.15% | US#1,886/3,112 Sec#109/206 |
| Op. Margin | 3.72% | US#2,181/3,112 Sec#110/206 |
| Revenue Growth | -12.29% | US#2,704/3,112 Sec#197/206 |
| Financial Health | ||
| Debt Ratio | 90.05% | US#983/3,112 Sec#99/206 |
| Total Debt | $1.34B | US#1,331/3,112 Sec#72/206 |
| FCF | $80M | US#1,761/3,112 Sec#108/206 |
| Cash | $288M | US#1,461/3,112 Sec#81/206 |
| Current Ratio | 2.30x | US#1,090/3,112 Sec#104/206 |
| Net Debt/EBITDA | 4.01x | US#1,883/3,112 Sec#117/206 |
| Performance | ||
| 1Y Return | 35.79% | US#1,115/3,112 Sec#71/206 |
| 1M Return | 11.63% | US#440/3,112 Sec#40/206 |
| From 52W High | -1.83% | US#196/3,112 Sec#10/206 |
| 1Y MDD | -27.18% | US#1,168/3,112 Sec#37/206 |
| Trading | ||
| Volume | 517,458 shares | US#2,046/3,112 Sec#152/206 |
| Trading Value | $90M | US#989/3,112 Sec#80/206 |
| Per Share | ||
| EPS | $0.03 | US#2,054/3,112 Sec#110/206 |
| BPS | $86.03 | US#151/3,112 Sec#11/206 |
Company Info
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.